Thymatron® System IV - Integrated ECT Instrument

Description
EXTENDED LOWER STIMULUS RANGE--ULTRABRIEF STIMULATION
Pulsewidth and frequency settings down to Ultrabrief and 20 Hz allow you to deliver stimuli up to 8 seconds long across the entire dosage range, to optimize treatment in accordance with research showing greater efficacy of short-pulsewidth, low-frequency, extended-duration stimuli (Isenberg et al, 1996; Chanpattana, 2001).
POSTICTAL SUPPRESSION INDEX
The Postictal Suppression Index reports the degree of EEG flattening immediately following the seizure, which has been reported to correlate with clinical efficacy (Nobler et al, 1993; Krystal & Weiner, 1994; Krystal et al, 1995; Krystal, 1998; Suppes et al, 1996; Petrides et al, 2000; Perera et al, 2002).
STATE-OF-THE-ART MONITOR/PRINTER
Allows you to monitor EEG1, EEG2, EKG, and EMG (or, choose 4 channels of EEG), plus 2 derived channels: digital heart rate and anesthesia depth index, while providing hard-copy documentation for the patient's chart.
IMPROVED FRONT-PANEL FLEXDIAL© SELECTOR
Lets you select all the traditional Thymatron® functions plus important new ones, including Ultrabrief pulse stimulation and programs that automatically set the most effective combination of stimulus parameters at any stimulus dose you have selected.
EXPANDED, COMPREHENSIVE END-OF-TREATMENT REPORT
Now includes, in addition to the familiar Thymatron® DGx measures, your choice of the following measures unique to the Thymatron® System IV:
EEG COHERENCE MEASURES of maximum sustained coherence and time to peak coherence, interhemispheric cross-correlation measures reported to reflect seizure quality and clinical impact (Roemer et al, 1990-91; Krystal & Weiner, 1994; Krystal et al, 1995; Krystal, 1998; Perera et al, 2002).
EEG AMPLITUDE MEASURES of maximum sustained EEG power, and time to peak power, with separate values for early, mid- and postictal seizure phases, found by the Columbia and Duke University groups to be important correlates of seizure quality and efficacy (Nobler et al, 1993, 2000; Krystal & Weiner, 1994; Krystal et al, 1995; Suppes et al, 1996; Krystal, 1999; Perera et al, 2002).
HEART RATE MEASURES, including peak heart rate, a key measure of cerebral seizure duration and quality (Larson, Swartz, & Abrams, 1984; Swartz, 1993; 1996) that reflects the autonomic (brainstem) response to ECT. This is supplemented by continuous digital heart rate monitoring for safety and seizure generalization, with the result printed each second on the recording strip.
POWERFUL DIGITAL PROCESSING
Employs Power Spectral Analysis (FFT) to process and store up to 10 minutes of digitized EEG for the special features described here. You can send this data to any WINDOWS computer via a rear-panel serial port for further comprehensive EEG analysis.
DIGITAL EEG MACHINE FUNCTIONS
The Thymatron® System IV has all the functions of a sophisticated 4-CHANNEL DIGITAL EEG MACHINE with frequency, coherence, asymmetry, and power spectral analytic programs. These allow you to record and analyze EEGs in your ECT patients between treatments to measure ECT-induced frontal EEG slowing and other EEG manifestations reported to reflect treatment impact and efficacy (Fink & Kahn, 1957; Roemer et al, 1990-91; Sackeim et al, 1996).
Because each ECT treatment session is STORED IN MEMORY, you can retrieve it if you run out of paper during a treatment -- just slip in another pack after the treatment and press a button for a complete printout.
PATENTED INDEPENDENT SAFETY MONITOR CIRCUIT AND ALARM
Prevents the patient from receiving an excessive electrical dose regardless of the operation of the regular circuits.
TRUE EMG RECORDING OF THE MOTOR SEIZURE
Unlike simple movement detectors, the Thymatron® System IV's EMG can measure seizure muscle activity that is not visible to the naked eye, and which typically continues substantially longer than visible movements (Couture et al, 1988).
JUST SET ACCORDING TO AGE AND TREAT
Setting the Thymatron® System IV according to the patient's age facilitates easy selection of a stimulus charge for unilateral, bitemporal, or bifrontal ECT that is in the preferred range (Beale et al, 1994; Petrides & Fink, 1996). The single dosage dial configuration also facilitates rapid stimulus titration using the latest age-based titration steps.
EASY ON-SITE UPGRADES
Because the special computer-automated programs of the Thymatron® System IV are stored on REPLACEABLE MICROCHIPS, future system updates (there have been SEVERAL already) can easily be accomplished via chip replacement.
SEIZURE ENERGY INDEX
A new, improved Average Seizure Energy Index measures a dimension of the seizure -- its intensity -- that is not reflected in seizure duration (Nobler et al, 1993, 2000; Krystal & Weiner, 1994; Krystal et al, 1995; Suppes et al, 1996; Krystal, 1999; Perera et al, 2002).
PRINTOUT OF SEIZURE DURATION BY EEG, EMG, AND EKG CRITERIA
The Thymatron® System IV measures the EEG, EMG, and EKG, and automatically prints the corresponding seizure duration estimates with precision and reliability Larson, Swartz and Abrams, 1984; Swartz et al, 1994; Krystal et al, 1995).
THE PATENTED AUDIBLE EEG©
Provides continuous EEG monitoring even if the recording paper runs out. It correlates highly with the visual EEG and keeps you constantly aware of the progress of the EEG seizure without having to watch the recording (Swartz & Abrams, 1986).
EXTENDED SEIZURE ALERT
Because longer seizures generate more cognitive side-effects, may clinicians prefer to terminate seizures that exceed 120 to 180 seconds on the EEG (Abrams, 2002). To advise the clinician that this point has been reached, the Thymatron® System IV provides an intermittent click tone when a user-selected interval has elapsed after the stimulus and monitoring has not been terminated.
RAPID STIMULUS TITRATION
Is facilitated with the Thymatron® System IV using a simple method-of-limits procedure (McCall et al, 1993; Rasmussen et al, 1994) or the newest method using age-based titration steps.
Specifications
Current: | 0.9 A constant, isolated from line current |
Frequency: | 10 to 70 Hz in 10 Hz increments (to 140 Hz for 0.25 ms pulse) |
Pulsewidth: | 0.25 to 1.5 ms in 0.25 ms increments. The Thymatron System IV is available with either 0.25 or 0.30 ms pulsewidth for ultrabrief stimuli, but not both. In North America the customer can specify his choice. In some countries the ultrabrief pulsewidth provided is according to standard practice there. |
Duration: | 0.14 to 8.0 s in increments of equal charge |
Maximum: | 504 mC (99.4 J @ 220 ohm); 1008 mC (188.8 J @220 ohm) with double-dose option (where available) |
Recording
8 user-selectable gain positions for EEG channels (10, 20, 50, 100, 200, 500, and 2000 µV/cm) and EMG/ECG channels (50, 100, 250, 500, 1000, 2500, 5000 and 10,000 µV/cm)
Requirements
100-130 volts A.C., 60 Hz, single phase. 100 VA./220-240 volts, 50/60 Hz switchable.
Approvals
CSA, CE, ISO 13485:2003, TUV, IEC 60601
A one-page course in Advanced Electroconvulsive Therapy

This sample ECT report of the Thymatron® System IV shows that the doctor set the % Energy dial to the patient's age of 45 years, yielding a 308 mC stimulus charge. The Optimal Charge Rate Program selected a 1/4 msec pulsewidth, 70 Hz frequency stimulus delivered over 7.2 sec. Prior to stimulus administration the impedance measured a safe 1440 ohms, which dropped to 260 ohms during stimulus delivery.
The EEG seizure lasted 48 seconds. Peak seizure amplitude was reached at 31 sec, with a Midictal Amplitude of 264 µV, a Maximum Sustained Power of 77841 µV2, and an Average Seizure Energy Index of 72µV2 all reflecting strong seizure intensity.
Peak Interhemispheric Coherence reached at 33 sec was consistent with the seizure amplitude peak at 31 sec. The Maximum Sustained Coherence value of 95% reflected synchronous participation of both hemispheres in the seizure. The rapid drop of EEG seizure amplitude to 10 µV postictally yielded a high Postictal Suppression Index of 96%. Power Spectral Analysis was not enabled.
In summary, the record shows a synchronous, high-intensity, well-developed, and well-generalized EEG seizure pattern with a strong mid-ictal phase, pronounced postictal suppression, and a substantial tachycardia response—which is to say, an ECT-induced seizure of high expected clinical efficacy (Abrams, 2002).